Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Receivables (2020 - 2025)

Historic Receivables for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $60.9 million.

  • GeneDx Holdings' Receivables rose 5944.01% to $60.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $60.9 million, marking a year-over-year increase of 5944.01%. This contributed to the annual value of $37.6 million for FY2024, which is 1624.29% up from last year.
  • GeneDx Holdings' Receivables amounted to $60.9 million in Q3 2025, which was up 5944.01% from $48.0 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Receivables high stood at $60.9 million for Q3 2025, and its period low was $21.7 million during Q3 2021.
  • For the 5-year period, GeneDx Holdings' Receivables averaged around $37.4 million, with its median value being $35.8 million (2023).
  • Its Receivables has fluctuated over the past 5 years, first soared by 11658.51% in 2022, then crashed by 3201.52% in 2023.
  • Over the past 5 years, GeneDx Holdings' Receivables (Quarter) stood at $26.6 million in 2021, then soared by 66.15% to $44.1 million in 2022, then fell by 26.65% to $32.4 million in 2023, then grew by 16.24% to $37.6 million in 2024, then surged by 61.94% to $60.9 million in 2025.
  • Its Receivables stands at $60.9 million for Q3 2025, versus $48.0 million for Q2 2025 and $46.0 million for Q1 2025.